article thumbnail

Ozempic, WeGovy, Trulicity: How GLP-1s influence Pharma and HealthTech shares

Lloyd Price

Understanding and Development (1990s-2000s): 1990s: Research delves into the GLP-1 receptor and its role in regulating metabolism. 2004: First GLP-1 receptor agonist (GLP-1 RA), exenatide, approved for type 2 diabetes treatment. 1996: Studies suggest GLP-1's potential in managing type 2 diabetes and obesity.